Overview

Efficacy of 300mg Ibuprofen Prolonged-Release Tablets for the Treatment of Pain After Surgical Removal of Impacted Third Molars

Status:
Unknown status

Trial end date:
2019-12-01

Target enrollment:

Participant gender:

Summary

This is a single centre, randomised, double-blind, double-dummy, parallel group, multiple-dose, active and placebo-controlled efficacy study to evaluate the efficacy and safety of 2×300mg ibuprofen Prolonged Release (PR) tablets in subjects with postoperative dental pain.

Phase:

Phase 3

Details

Lead Sponsor:

Reckitt Benckiser Healthcare (UK) Limited

Collaborator:

Premier Research Group plc

Treatments:

Ibuprofen